Caleb Han
Overview
Explore the profile of Caleb Han including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
1
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leguizamon M, Han C, Garza M, Horne M, Richerson W, Davis L, et al.
AJNR Am J Neuroradiol
. 2025 Feb;
PMID: 39993797
Background And Purpose: Anatomical imaging is a hallmark for visualizing chronic and acute infarcts but provides incomplete information on stroke risk. Respiratory hypercapnic gas challenges show promise for non-invasively assessing...
2.
Shiino S, Han C, Garza M, Fusco M, Chitale R, Davis L, et al.
J Neurosurg
. 2025 Feb;
:1-11.
PMID: 39951721
Objective: Both direct and indirect surgical revascularization techniques are commonly applied for the treatment of moyamoya disease and syndrome; however, responses can be heterogeneous and efficacy in the context of...
3.
Han C, Richerson W, Garza M, Rodeghier M, Mishra M, Davis L, et al.
Brain Commun
. 2025 Jan;
7(1):fcae381.
PMID: 39801713
Moyamoya is a non-atherosclerotic intracranial steno-occlusive condition that places patients at high risk for ischaemic stroke. Randomized trials of surgical revascularization demonstrating efficacy in ischaemic moyamoya have not been performed,...
4.
Pierobon Mays G, Hett K, Eisma J, McKnight C, Elenberger J, Song A, et al.
Fluids Barriers CNS
. 2024 May;
21(1):40.
PMID: 38725029
Background: Parkinson's disease is characterized by dopamine-responsive symptoms as well as aggregation of α-synuclein protofibrils. New diagnostic methods assess α-synuclein aggregation characteristics from cerebrospinal fluid (CSF) and recent pathophysiologic mechanisms...
5.
Cerebrovascular reactivity dispersion as a new biomarker of recent stroke symptomatology in moyamoya
Han C, Richerson W, Garza M, Rodeghier M, Mishra M, Davis L, et al.
medRxiv
. 2024 Mar;
PMID: 38463978
Background: Moyamoya disease (MMD) is a non-atherosclerotic intracranial steno-occlusive condition placing patients at high risk for ischemic stroke. Direct and indirect surgical revascularization can improve blood flow in MMD; however,...
6.
Han C, Waddle S, Garza M, Davis L, Eisma J, Richerson W, et al.
J Neuroimaging
. 2023 Oct;
34(1):152-162.
PMID: 37885135
Background And Purpose: Choroid plexus (ChP) hyperemia has been observed in patients with intracranial vasculopathy and to reduce following successful surgical revascularization. This observation may be attributable to impaired vascular...
7.
Pierobon Mays G, Hett K, Eisma J, McKnight C, Elenberger J, Song A, et al.
Res Sq
. 2023 Sep;
PMID: 37720044
Background: Parkinson's disease is characterized by dopamine-responsive symptoms as well as aggregation and accumulation of a-synuclein protofibrils. New diagnostic methods assess a-synuclein aggregation characteristics from cerebrospinal fluid and recent pathophysiologic...